Trials / Completed
CompletedNCT01333722
Acute Pain Study Following Bunionectomy
A Randomized, Multicenter Study Comparing the Analgesic Efficacy and Safety of Hydrocodone / Acetaminophen Extended Release to Placebo in Subjects With Acute Pain Following Bunionectomy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- AbbVie (prior sponsor, Abbott) · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study was to evaluate analgesic efficacy and safety of hydrocodone/acetaminophen extended release compared to placebo in the treatment of moderate to severe pain following bunionectomy.
Detailed description
The bunionectomy was performed under regional anesthesia and propofol sedation. Perioperative anesthesia was standardized for all participants. Upon completion of surgery, designated study personnel ensured continued eligibility per the selection criteria of the protocol. After an appropriate period of time following bunionectomy, participants who had a pain intensity score of ≥ 40 mm on a 100 mm visual analog scale (VAS) and moderate or severe pain intensity per the categorical pain intensity scale were eligible for randomization, in equal numbers, into 1 of 2 treatment arms: hydrocodone/acetaminophen extended release or placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydrocodone/Acetaminophen Extended Release | |
| DRUG | Placebo | Placebo tablet |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2011-04-12
- Last updated
- 2014-04-08
- Results posted
- 2014-03-07
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01333722. Inclusion in this directory is not an endorsement.